Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept for Sjogren's Syndrome
NCT00001954Phase 2Completed
- Sponsor
- National Institute of Dental and Craniofacial Research
- Start
- Dec 1999
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sjogren's syndrome comparing Etanercept with Placebo (2 arms). Primary endpoints: Salivary gland function at 4 months and Lacrimal gland function at 4 months. Started Dec 1999; status: completed.
02
Drugs
etanercept
03
Conditions
Sjogren's syndrome
Beyond the preview
Go deeper on NCT00001954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001954.